Generate Biomedicines
Nasdaq GENB · Somerville, MA
Works in Dermatology · Genetic & rare · Immunology · Neurology · Oncology · Respiratory
Generate Biomedicines is a clinical trial sponsor based in Somerville, MA, listed as Nasdaq GENB. It has 5 active clinical trials with 1,805 planned participants, across 6 therapeutic areas. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq GENB
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Generate Biomedicines
Generate Biomedicines is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 1,805 planned participants, in Dermatology, Genetic & rare, Immunology, Neurology and other areas. Since 2021 it has completed 1 trial and stopped 0 early.
Generate Biomedicines is based in Somerville, MA and is listed as Nasdaq GENB. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Generate Biomedicines; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-13.
Approve Suite is not affiliated with Generate Biomedicines. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.